Business Context and Reporting Period
This Form 8-K Current Report was filed by Herbalife Ltd. on March 7, 2024, covering events that occurred on March 1, 2024. The filing addresses corporate governance changes regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Resignation: Kevin M. Jones resigned from the Board of Directors on March 1, 2024. The resignation was voluntary and did not result from any disagreement with the Company regarding operations, policies, or practices.
- Appointment: Michael J. Levitt was appointed to the Board on March 1, 2024, to fill the vacancy created by Mr. Jones's departure.
Guidance, Outlook, and Risks
Compensation and Agreements: Mr. Levitt's compensation will align with the Company's plan for non-employee directors as described in the 2023 Definitive Proxy Statement. He will also enter into the Company's standard indemnification agreement.
Conflicts of Interest: The Company confirmed there is no arrangement or understanding pursuant to which Mr. Levitt was appointed. Furthermore, the Company has not participated in any transaction since the beginning of its last fiscal year involving Mr. Levitt or his immediate family that would constitute a material interest.
Investor Verification Checklist
- Verify the biographical background and qualifications of the newly appointed director, Michael J. Levitt.
- Review the Company's Definitive Proxy Statement on Schedule 14A (filed March 14, 2023) to confirm the specific compensation structure for non-employee directors.
- Confirm that the resignation of Kevin M. Jones was not related to any undisclosed governance or operational disputes.